
India puts big pharma concessions on table as US trade deal nears finish line
According to two people familiar with the matter, India’s proposals include supply of low-cost complex generic medicines at sharply reduced costs, patent reforms to allow earlier entry of generics in the US, increased US-based manufacturing by Indian …